Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Apr 25, 2022 7:00 AM - Apr 27, 2022 12:00 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Session 9: Hot Topics

Session Chair(s)

Arthur A. Levin, PhD

Arthur A. Levin, PhD


Avidity Biosciences , United States

Emily  Place, PhD, MPH

Emily Place, PhD, MPH

Senior Consultant

Biologics Consulting, United States

Attendees at this session will hear about novel technologies that are bridging the gap between early research and clinical development. Each is an area that holds the promise of creating a new platform for oligonucleotide therapeutics. Featured in this session are:

  • A novel delivery platform using a conjugate approach
  • Circular RNAs as potential therapeutics
  • A novel and personalized aptamer technology in oncology

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss insights into the promise of these technologies and how these technologies have the potential for broad applications
  • Explore where the oligonucleotide therapeutics field will advance in the future


Irit  Carmi-Levy, PhD

AUMMUNE Therapy Driven by Effect

Irit Carmi-Levy, PhD

Aummune, Israel

Chief Scientific Officer and Vice President R&D

Chris  Duke, MBA, MPH

A Novel Antibody Platform for Nucleic Acid Delivery with Broad Therapeutic Potential

Chris Duke, MBA, MPH

Gennao Bio, United States

Cheif Operating Officer

Robert  Mabry, PhD

The Therapeutic Potential of oRNA

Robert Mabry, PhD

Orna Therapeutics, Inc. , United States

Chief Scientific Officer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.